Novel Vaccine Delivery Devices Market is estimated to be worth USD 1.5 billion in 2030

1. Novel Vaccine Delivery Devices Market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient Roots Analysis is pleased to announce the publication of its recent study, titled, “Novel Vaccine Delivery Devices Market, 2019-2030” The report features an extensive study of the current landscape and the likely future opportunities associated with novel vaccine delivery devices, over the next 10-12 years. Amongst other elements, the report includes:  A detailed assessment of the overall novel vaccine delivery devices market landscape, featuring an elaborate list of device developers engaged in the development of novel vaccine delivery devices. A detailed competitiveness analysis of novel vaccine delivery devices, taking into consideration the supplier power and key product specifications. An analysis evaluating the effectiveness of various vaccines delivery devices in order to compare their respective strengths and capabilities based on a variety of parameters. A detailed list of marketed and pipeline vaccine candidates that are anticipated to be developed in combination with novel vaccine delivery devices in the near future. Elaborate profiles of prominent product developers engaged in the novel vaccine delivery devices domain (shortlisted on the basis of the number of pipeline products). An analysis of the partnerships that have been established in this domain, in the recent past. A discussion on important, industry-specific trends, key market drivers and challenges, under a comprehensive SWOT framework.       A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) Request for Customization: https://www.rootsanalysis.com/reports/280/request-customization.html Global Novel Vaccine Delivery Devices (By Value) Type of Device       Electroporation-based Needle Free Injection Systems Oral Delivery Systems Nasal Delivery Systems Jet Injectors Microneedle Patches Microinjectors Route of Administration

2.      Oral Intramuscular Intranasal Intradermal Subcutaneous Type of Vaccines         Bivalent Oral Polio Vaccine BCG Vaccine DTP-HepB-Hib Vaccine Pneumococcal Conjugate Vaccine Influenza Vaccine Measles Vaccine Tetanus-Diphtheria Vaccine Others Key Geographical Region     North America Europe Asia Pacific Rest of the World Key companies covered in the report           3M Becton Dickinson Consort Medical D’Antonio Consultants International Enesi Pharma Ichor Medical Iconovo Inovio Pharmaceuticals PharmaJet Union Medico Download PDF Sample: https://www.rootsanalysis.com/reports/280/request-sample.html About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 Gaurav.Chaudhary@rootsanalysis.com